Filing Details
- Accession Number:
- 0000899243-18-019736
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-11 16:05:47
- Reporting Period:
- 2018-07-09
- Accepted Time:
- 2018-07-11 16:05:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1512762 | Coherus Biosciences Inc. | CHRS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242116 | K Barbara Finck | Coherus Biosciences, Inc. 333 Twin Dolphin Drive, Suite 600 Redwood City CA 94065 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Acquisiton | 2018-07-09 | 500 | $1.42 | 37,543 | No | 4 | M | Direct | |
| Common Stock, $0.0001 Par Value | Disposition | 2018-07-09 | 500 | $15.03 | 37,043 | No | 4 | S | Direct | |
| Common Stock, $0.0001 Par Value | Acquisiton | 2018-07-10 | 1,260 | $1.42 | 38,303 | No | 4 | M | Direct | |
| Common Stock, $0.0001 Par Value | Disposition | 2018-07-10 | 1,260 | $15.00 | 37,043 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-07-09 | 500 | $0.00 | 500 | $1.42 |
| Common Stock | Stock Option(right to buy) | Disposition | 2018-07-10 | 1,260 | $0.00 | 1,260 | $1.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 87,721 | 2023-11-23 | No | 4 | M | Direct | |
| 86,461 | 2023-11-21 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
- The shares underlying this option are fully vested and exercisable as of the date hereof.
Billionaire Hedge Funds
